Canadian rheumatology association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: Part II safety Review uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid

abstract

  • These recommendations were developed based on a synthesis of international RA and public health guidelines, supporting evidence, and expert consensus in the context of the Canadian health system. They are intended to help promote best practices and improve healthcare delivery for persons with RA.

publication date

  • August 2012

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3899/jrheum.120165

PubMed ID

  • 22707613

Additional Document Info

start page

  • 1583

end page

  • 602

volume

  • 39

number

  • 8